drugset / Trial / NCT02655757
Effect of Sitagliptin on Progression of Coronary Intermediate Lesion
RandomizedParallel-groupOpen-labelTreatment
Summary
This study was to investigate the Effect of Sitagliptin, a dipeptidyl peptidase-4 inhibitor, on Progression of Coronary Intermediate Lesion.
Timeline
- Start
- 2015-12
- Primary completion
- 2017-02-02
- Completion
- 2017-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sitagliptin | Small molecule | 5 mg | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | — |